Symbiotic Therapeutics Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2000.
2000 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Symbiotic Therapeutics Private Limited

Symbiotic Therapeutics Private Limited, a active private limited company, was established on 23 June 2000 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51109DL2000PTC106441. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.

It upholds a compliant status. Employing 144 professional, Its leadership includes Bhupender Kaushal (Director), Sanjay Guleria (Director). Past directors included Kalpana Kaushal, Bhupender Kaushal, Babita Guleria. It holds ₹9.50 M open charges and ₹2.20 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 305Mahajan Tower Plot No 7 L.Sc Shreshtha Vihar, New Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51109DL2000PTC106441

  • Registration Number

    106441

  • Incorporation Date

    23 June 2000

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹3.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 3.00 M
  • Company Age 25 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 9.50 M
  • Satisfied Charges ₹ 2.20 Cr
  • Revenue Growth **** 0.94%
  • Profit Growth **** -21.26%
  • Ebitda **** 9.74%
  • Net Worth 13.90%
  • Total Assets **** 7.35%
Company report

Symbiotic Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Symbiotic Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Symbiotic Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Bhupender Kaushal Director 23 Jun 2000 Current
Sanjay Guleria Director 23 Jun 2000 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Aug 2009 Past
Pramod Abcsdd Director - Past
Pramod Abcsdd Director 01 Aug 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Symbiotic Therapeutics.

Symbiotic Therapeutics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.94% increase. The company also saw a substantial fall in profitability, with a 21.26% decrease in profit. The company's net worth Soared by an impressive increase of 13.9%.

Symbiotic Therapeutics revenue growth over time
Symbiotic Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.94%
*******
*******
*******
*******
Revenue from Operations
*******
 0.96%
*******
*******
*******
*******
Total Assets
*******
 7.35%
*******
*******
*******
*******
Profit or Loss
*******
 -21.26%
*******
*******
*******
*******
Net Worth
*******
 13.90%
*******
*******
*******
*******
EBITDA
*******
 9.74%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Symbiotic Therapeutics?

Unlock access to Symbiotic Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹9,500,000.00

Satisfied Charges

₹22,004,450.00

Charges Breakdown by Lending Institutions
  • Punjab National Bank : 0.95 Cr
Latest Charge Details
Date Lender Amount Status
20 Apr 2005 Punjab National Bank ₹9.50 M Open
20 Jun 2019 Others ₹2.50 M Satisfied
26 Oct 2018 Others ₹1.00 M Satisfied
30 Jan 2013 Punjab National Bank ₹0.85 M Satisfied
08 Aug 2008 Member Secretary ₹1.51 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Symbiotic Therapeutics?

Symbiotic Therapeutics has a workforce of 144 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Symbiotic Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiotic Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Symbiotic Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Symbiotic Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Symbiotic Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 26 Oct 2018 via Charge ID 100224139 with Others was fully satisfied on 21 Oct 2024. was documented.

  • Charges

    Progress on A charge registered on 20 Jun 2019 via Charge ID 100271363 with Others was fully satisfied on 16 Oct 2024. was documented.

  • Charges

    A charge registered on 30 Jan 2013 via Charge ID 10402647 with Punjab National Bank was fully satisfied on 29 Jul 2019. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 2.50 M with Charge ID 100271363 was registered on 20 Jun 2019. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Symbiotic Therapeutics Private Limited?

The CIN of Symbiotic Therapeutics Private Limited is U51109DL2000PTC106441.

Where is Symbiotic Therapeutics Private Limited headquartered?

Symbiotic Therapeutics Private Limited is headquartered at 305Mahajan Tower Plot No 7 L.Sc Shreshtha Vihar, New Delhi, Delhi, 110092.

When was Symbiotic Therapeutics Private Limited incorporated?

Symbiotic Therapeutics Private Limited was incorporated on 23 June 2000.

Who are the current directors of Symbiotic Therapeutics Private Limited?

The current directors of Symbiotic Therapeutics Private Limited are

What is the primary industry of Symbiotic Therapeutics Private Limited?

The primary industry of Symbiotic Therapeutics Private Limited is Manufacturing.

Is Symbiotic Therapeutics Private Limited a listed company?

Symbiotic Therapeutics Private Limited is unlisted.

What is the capital structure of Symbiotic Therapeutics Private Limited?

The authorized capital of Symbiotic Therapeutics Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.

What is the compliance status of Symbiotic Therapeutics Private Limited?

The compliance status of Symbiotic Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available